SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Jackie Heda

Cancer Therapy: DSP-7888 

Prev Next
Previous

Alvocidib

medical illustration of DSP-7888 is an investigational cancer vaccine containing two peptides that induce WT1-specific cytotoxic T lymphocytes and helper cells to attack WT1-expressing cancerous cells found in various types of hematologic malignancies and solid tumors. Researchers have found that adding helper T-cell-inducing peptides, improved outcomes may be achieved compared with a treatment regimen that induced only WT1-CTL's.
#cancer therapy  DSP-7888 #cancer cell apotheosis #T- cell #cytotoxic lymphoma
Next

DSP-7888 is an investigational cancer vaccine containing two peptides that induce WT1-specific cytotoxic T lymphocytes and helper cells to attack WT1-expressing cancerous cells found in various types of hematologic malignancies and solid tumors. Researchers have found that adding helper T-cell-inducing peptides, improved outcomes may be achieved compared with a treatment regimen that induced only WT1-CTL's. #cancer therapy DSP-7888 #cancer cell apotheosis #T- cell #cytotoxic lymphoma

Keywords: 3D, Education, Professional Education, Disease Management, Pharmacology, Oncology

© Jackie Heda